Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 306
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02583542 | A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | ||
| NCT00993655 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | ||
| NCT07209774 | Healthspan Connect Programme of Research | ||
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC | ||
| NCT00595777 | Edinburgh Pain Assessment Tool (EPAT©) Study | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT01431664 | AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia | ||
| NCT04226937 | DLBCL Interim Response Evaluation for Customised Therapy | ||
| NCT02121639 | Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | ||
| NCT02544308 | Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma | ||
| NCT00963092 | Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT03371485 | AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer | ||
| NCT00411138 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | ||
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | ||
| NCT00641095 | Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma | ||
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | ||
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations | ||
| NCT01602588 | A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) | ||
| NCT02308527 | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children | ||
| NCT01679119 | Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy | ||
| NCT02530411 | Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer | ||
| NCT00801736 | ERCC1 Targeted Trial | ||
| NCT03610100 | Acelarin First Line Randomised Pancreatic Study | ||
| NCT00080912 | Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases | ||
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition | ||
| NCT02330926 | Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy | ||
| NCT00058032 | CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women | ||
| NCT00669812 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | ||
| NCT03424668 | The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study | ||
| NCT01977638 | Phase 1 Trial of CXD101 in Patients With Advanced Cancer | ||
| NCT05541601 | Prospective Cohort for Early Detection of Liver Cancer | ||
| NCT02403102 | Imageguided Theranostics in Multiple Myeloma | ||
| NCT04063566 | ReIMAGINE Prostate Cancer Screening | ||
| NCT01836692 | Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study | ||
| NCT00958854 | Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT00727831 | Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | ||
| NCT02308072 | Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | ||
| NCT06714630 | The PROSECCA Study, Answering New Questions in Prostate Cancer | ||
| NCT02695966 | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | ||
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT04271371 | Preventing Relapse to Smoking Among Prisoners After Release | ||
| NCT03687645 | Hyperpolarised 13C-Pyruvate MRI Study | ||
| NCT04409444 | Manchester Lung Health Study | ||
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. | ||
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | ||
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer |
